Literature DB >> 27069267

Differentiating giant cell tumor of bone from patellofemoral syndrome: a case study.

Jason Bonar1, Shannon Clutton Carr2, Diana De Carvalho3, Jay S Wunder4.   

Abstract

Balancing the assessment of musculoskeletal dysfunctions with a high level of suspicion for non-mechanical origins can be a challenge for the clinician examining a sports injury. Without timely diagnosis, non-mechanical complaints could result in surgery or loss of limb. This case describes the discovery of a Giant Cell Tumor of Bone (GCTB) following the re-evaluation of an athlete who had undergone five years of conservative management for patellofemoral pain syndrome (PFPS). Knee injuries account for 32.6% of sports injuries with PFPS being the most common and most likely diagnosis for anterior knee pain. GCTB is a benign aggressive bone tumor with a predilection for the juxta-articular region of the knee, comprising up to 23% of all benign bone tumors, and commonly occurs in the second to fourth decades. This case report illustrates the difficulty in accurately diagnosing healthy athletes, reviews common differentials for knee complaints and explores helpful diagnostic procedures.

Entities:  

Keywords:  bone neoplasms; chiropractic; diagnostic errors; patellofemoral pain syndrome; sports medicine

Year:  2016        PMID: 27069267      PMCID: PMC4807683     

Source DB:  PubMed          Journal:  J Can Chiropr Assoc        ISSN: 0008-3194


  25 in total

1.  Intrinsic risk factors for the development of anterior knee pain in an athletic population. A two-year prospective study.

Authors:  E Witvrouw; R Lysens; J Bellemans; D Cambier; G Vanderstraeten
Journal:  Am J Sports Med       Date:  2000 Jul-Aug       Impact factor: 6.202

Review 2.  The influence of abnormal hip mechanics on knee injury: a biomechanical perspective.

Authors:  Christopher M Powers
Journal:  J Orthop Sports Phys Ther       Date:  2010-02       Impact factor: 4.751

3.  Hip strength and hip and knee kinematics during stair descent in females with and without patellofemoral pain syndrome.

Authors:  Lori A Bolgla; Terry R Malone; Brian R Umberger; Timothy L Uhl
Journal:  J Orthop Sports Phys Ther       Date:  2007-11-21       Impact factor: 4.751

Review 4.  Does quadriceps atrophy exist in individuals with patellofemoral pain? A systematic literature review with meta-analysis.

Authors:  Lachlan S Giles; Kate E Webster; Jodie A McClelland; Jill Cook
Journal:  J Orthop Sports Phys Ther       Date:  2013-09-09       Impact factor: 4.751

Review 5.  Risk factors for meniscal tears: a systematic review including meta-analysis.

Authors:  Barbara A M Snoeker; Eric W P Bakker; Cornelia A T Kegel; Cees Lucas
Journal:  J Orthop Sports Phys Ther       Date:  2013-04-29       Impact factor: 4.751

6.  Femur rotation and patellofemoral joint kinematics: a weight-bearing magnetic resonance imaging analysis.

Authors:  Richard B Souza; Christie E Draper; Michael Fredericson; Christopher M Powers
Journal:  J Orthop Sports Phys Ther       Date:  2010-05       Impact factor: 4.751

7.  Giant cell tumor of long bone: a Canadian Sarcoma Group study.

Authors:  Robert E Turcotte; Jay S Wunder; Marc H Isler; Robert S Bell; Norman Schachar; Bassam A Masri; Guy Moreau; Aileen M Davis
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

Review 8.  Giant cell tumor of bone: review, mimics, and new developments in treatment.

Authors:  Corey J Chakarun; Deborah M Forrester; Christopher J Gottsegen; Dakshesh B Patel; Eric A White; George R Matcuk
Journal:  Radiographics       Date:  2013 Jan-Feb       Impact factor: 5.333

9.  The epidemiology of musculoskeletal tendinous and ligamentous injuries.

Authors:  Robert A E Clayton; Charles M Court-Brown
Journal:  Injury       Date:  2008-11-25       Impact factor: 2.586

Review 10.  The relative timing of VMO and VL in the aetiology of anterior knee pain: a systematic review and meta-analysis.

Authors:  Rachel Chester; Toby O Smith; David Sweeting; John Dixon; Sarah Wood; Fujian Song
Journal:  BMC Musculoskelet Disord       Date:  2008-05-01       Impact factor: 2.362

View more
  1 in total

1.  Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.

Authors:  Josef Yayan
Journal:  Cancer Control       Date:  2020 Jul-Aug       Impact factor: 3.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.